Search research articles
Contact Us
Filters
Showing results (231-240 of 245) with videos related to
Page
of 25
Sort By:
Journal of Medicinal Chemistry
|
January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Journal of Medicinal Chemistry
|
April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase
Brian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Journal of Hepatology
|
March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
Stefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.
Gastroenterology
|
August 9, 2013
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial
Fred Poordad, Eric Lawitz, K Rajender Reddy, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like
Shumei Wang, Vickie Tsui, Terry D Crawford, et al.
Journal of Hepatology
|
June 28, 2011
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients
Alexander J Thompson, Paul J Clark, Abanish Singh, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)
Terry D Crawford, James E Audia, Steve Bellon, et al.
Journal of Medicinal Chemistry
|
May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Nature Chemical Biology
|
May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 245) with videos related to
Sort By:
Page
of 25
Journal of Medicinal Chemistry
|
January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Journal of Medicinal Chemistry
|
April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase
Brian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Journal of Hepatology
|
March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
Stefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.
Gastroenterology
|
August 9, 2013
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial
Fred Poordad, Eric Lawitz, K Rajender Reddy, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like
Shumei Wang, Vickie Tsui, Terry D Crawford, et al.
Journal of Hepatology
|
June 28, 2011
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients
Alexander J Thompson, Paul J Clark, Abanish Singh, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)
Terry D Crawford, James E Audia, Steve Bellon, et al.
Journal of Medicinal Chemistry
|
May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Nature Chemical Biology
|
May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
Page
of 25